The Special Drug Use-results Survey on Long-term Use of Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg Fixed Dose Combination Tablets in Patients With Hypertension
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 22 Jan 2018
At a glance
- Drugs Amlodipine/telmisartan/hydrochlorothiazide (Primary)
- Indications Hypertension
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 16 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 19 Dec 2017 Status changed from active, no longer recruiting to recruiting.
- 05 Dec 2017 Status changed from recruiting to active, no longer recruiting.